Lataa...
Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer
Although oncogenic KRAS represents a therapeutically relevant target in pancreatic cancer, it is deemed “non-druggable” because of the intrinsic difficulty in designing direct inhibitors of KRAS. Our recent work demonstrated a KRAS-integrin-linked kinase (ILK) regulatory feedback loop that allows pa...
Tallennettuna:
| Julkaisussa: | Small GTPases |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6204986/ https://ncbi.nlm.nih.gov/pubmed/27936345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21541248.2016.1251383 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|